药物对比
Canagliflozin vs Tolazamide
Canagliflozin 是一种SGLT2抑制剂，通过影响肾脏重吸收来降低血糖，并具有心脏获益。Tolazamide 是一种促进胰岛素分泌的磺脲类药物。两者的副作用不同。
此页面暂无可用的对比维度。
临床背景
Individuals with type 2 diabetes seeking to compare SGLT2 inhibitors like Canagliflozin with sulfonylureas such as Tolazamide may consult this information when choosing oral antidiabetic therapy.
结论
Both Canagliflozin and Tolazamide are viable oral antidiabetic options, with the optimal choice varying based on individual patient factors.
全部药物对比